The LAM-SAFE Study: Lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults

This study indicates that the effectiveness of LTG in focal and generalised epilepsy syndromes as initial monotherapy in patients ≥12 years is in the range of standard first-line antiepileptic drugs.